158 related articles for article (PubMed ID: 36506256)
1. Comparison of Survival Outcomes and Risk Factors Between Ductal Carcinoma of the Prostate and Acinar Adenocarcinoma of the Prostate: A Population-based Propensity Score-matching Study.
Wei Y; Kobayashi T; Lu Y; Vogel M; Zhang R; Wu J; Gao Y; Lin L; Zhu Q; Ye L; Horie S; Wang X; Li T
Eur Urol Open Sci; 2022 Dec; 46():88-95. PubMed ID: 36506256
[TBL] [Abstract][Full Text] [Related]
2. Analysis of survival and prognostic factors of clear cell adenocarcinoma of the prostate: a case-control study for a rare cancer entity.
Chen S; Song W; Zhang R; Jin Y; Lu Y; Lin L; Ye L; Li T; Wei Y
Sci Rep; 2023 Jun; 13(1):10317. PubMed ID: 37365217
[TBL] [Abstract][Full Text] [Related]
3. Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study.
Zhao F; Yu X; Xu M; Ye S; Zang S; Zhong W; Ren G; Chen X; Yan S
Front Oncol; 2019; 9():1467. PubMed ID: 31998638
[No Abstract] [Full Text] [Related]
4. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.
Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Fossati N; Gandaglia G; Gallina A; Abdollah F; Shariat SF; Montorsi F; Saad F; Tilki D; Briganti A; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):381-388. PubMed ID: 29366856
[TBL] [Abstract][Full Text] [Related]
6. Oncological outcomes of patients with ductal adenocarcinoma of the prostate receiving radical prostatectomy or radiotherapy.
Liu M; Jin K; Qiu S; Xu P; Zhang M; Cai W; Zheng X; Yang L; Wei Q
Asian J Urol; 2021 Apr; 8(2):227-234. PubMed ID: 33996481
[TBL] [Abstract][Full Text] [Related]
7. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract][Full Text] [Related]
8. Primary Cardiac Sarcoma: Clinical Characteristics and Prognostic Factors over the Past 2 Decades.
Bangolo A; Fwelo P; Iyer KM; Klinger S; Tavares L; Dey S; Chacko AA; Hein M; Gudena S; Lawal G; Sivasubramanian BP; Rimba Z; Hirpara K; Merajunnissa M; Veliginti S; Arana G; Sathyarajan DT; Singh S; Shetty T; Bhardwaj K; Hashemy S; Duran RL; Kim SH; Hipolito CM; Yoon K; Patel V; Alshimari A; Inban P; Yasmeen S; Devanaboyina K; Kumar G; Preet S; Akhtar M; Abdi A; Nalajala N; Rizvi SFM; Gupta B; Weissman S
Diseases; 2023 May; 11(2):. PubMed ID: 37218887
[TBL] [Abstract][Full Text] [Related]
9. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis.
Moschini M; Zamboni S; Afferi L; Pradere B; Abufaraj M; Soria F; D'Andrea D; Roupret M; De la Taille A; Simeone C; Mattei A; Mathieu R; Bensalah K; Wirth MP; Montorsi F; Briganti A; Gallina A; Simone G; Gallucci M; Di Bona C; Marra G; Mari A; Di Trapani E; Alvarez Maestro M; Krajewski W; Shariat SF; Xylinas E; Baumeister P
Arab J Urol; 2020 Sep; 19(1):31-36. PubMed ID: 33763246
[TBL] [Abstract][Full Text] [Related]
10. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
11. Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study.
Bandini M; Pompe RS; Marchioni M; Zaffuto E; Gandaglia G; Fossati N; Cindolo L; Montorsi F; Briganti A; Saad F; Karakiewicz PI
Int Urol Nephrol; 2018 Jan; 50(1):71-78. PubMed ID: 29129028
[TBL] [Abstract][Full Text] [Related]
12. Cancer-directed surgery brings survival benefits for patients with advanced prostate cancer: a population-based propensity-score matching study.
Chen R; Lu Y; Horie S; Vogel M; Zhang R; Zheng P; Wei Y
J Cancer; 2023; 14(2):231-238. PubMed ID: 36741253
[No Abstract] [Full Text] [Related]
13. Adjuvant Radiotherapy in Prostate Cancer Patients Treated with Surgery: The Impact of Age and Tumor Characteristics.
Abdollah F; Karakiewicz PI; Gandaglia G; Dalela D; Klett DE; Shiffmann J; Montorsi F; Briganti A; Saad F; Graefen M; Peabody JO; Menon M; Sun M
Eur Urol Focus; 2015 Sep; 1(2):191-199. PubMed ID: 28723433
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.
Yao J; Liu Y; Liang X; Shao J; Zhang Y; Yang J; Zheng M
Front Endocrinol (Lausanne); 2021; 12():778758. PubMed ID: 34956090
[TBL] [Abstract][Full Text] [Related]
15. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
Wu T; Zhao J; Liu Z; Shen P; Zhang M; Sun G; Liu J; Liao B; Chen J; Zhu S; Dai J; Wang Z; Zhang H; Zhao P; Zhang X; Zhu X; Ni Y; Chen N; Zeng H
Prostate; 2019 Oct; 79(14):1673-1682. PubMed ID: 31433509
[TBL] [Abstract][Full Text] [Related]
16. Focal Laser Ablation Versus Radical Prostatectomy for Localized Prostate Cancer: Survival Outcomes From a Matched Cohort.
Zheng X; Jin K; Qiu S; Han X; Liao X; Yang L; Wei Q
Clin Genitourin Cancer; 2019 Dec; 17(6):464-469.e3. PubMed ID: 31594734
[TBL] [Abstract][Full Text] [Related]
17. Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature.
Cozzi S; Bardoscia L; Najafi M; Igdem S; Triggiani L; Magrini SM; Botti A; Guedea F; Melocchi L; Ciammella P; Iotti C; Gutierrez C
Curr Urol; 2022 Dec; 16(4):218-226. PubMed ID: 36714233
[TBL] [Abstract][Full Text] [Related]
18. Local Therapy Improves Survival in Metastatic Prostate Cancer.
Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
Huang J; Huang D; Yan J; Chen T; Gao Y; Xu D; Na R
Cancer Med; 2020 Dec; 9(24):9409-9418. PubMed ID: 33141518
[TBL] [Abstract][Full Text] [Related]
20. Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy.
Wenzel M; Würnschimmel C; Chierigo F; Mori K; Tian Z; Terrone C; Shariat SF; Saad F; Tilki D; Graefen M; Mandel P; Roos FC; Chun FKH; Karakiewicz PI
Eur Urol Focus; 2022 May; 8(3):710-717. PubMed ID: 33933420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
